An Overview of Privileged Scaffold: Quinolines and Isoquinolines in Medicinal Chemistry as Anticancer Agents
- PMID: 32942976
- DOI: 10.2174/1568026620999200917154225
An Overview of Privileged Scaffold: Quinolines and Isoquinolines in Medicinal Chemistry as Anticancer Agents
Abstract
Cancer is one of the most difficult diseases and causes of death for many decades. Many pieces of research are continuously going on to get a solution for cancer. Quinoline and isoquinoline derivatives have shown their possibilities to work as an antitumor agent in anticancer treatment. The members of this privileged scaffold quinoline and isoquinoline have shown their controlling impacts on cancer treatment through various modes. In particular, this review suggests the current scenario of quinoline and isoquinoline derivatives as antitumor agents and refine the path of these derivatives to find and develop new drugs against an evil known as cancer.
Keywords: Anticancer; Antiproliferative; Antitumor; Inhibition; Isoquinoline; Quinoline.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
An overview of quinoline as a privileged scaffold in cancer drug discovery.Expert Opin Drug Discov. 2017 Jun;12(6):583-597. doi: 10.1080/17460441.2017.1319357. Epub 2017 Apr 20. Expert Opin Drug Discov. 2017. PMID: 28399679 Review.
-
Recent contributions of quinolines to antimalarial and anticancer drug discovery research.Eur J Med Chem. 2021 Dec 15;226:113865. doi: 10.1016/j.ejmech.2021.113865. Epub 2021 Sep 23. Eur J Med Chem. 2021. PMID: 34655985 Review.
-
Quinoline as a privileged scaffold in cancer drug discovery.Curr Med Chem. 2011;18(10):1488-508. doi: 10.2174/092986711795328382. Curr Med Chem. 2011. PMID: 21428893 Review.
-
Tailored Quinolines Demonstrate Flexibility to Exert Antitumor Effects through Varied Mechanisms-A Medicinal Perspective.Anticancer Agents Med Chem. 2021;21(3):288-315. doi: 10.2174/1871520620666200908104303. Anticancer Agents Med Chem. 2021. PMID: 32900354 Free PMC article. Review.
-
A review on anticancer potential of bioactive heterocycle quinoline.Eur J Med Chem. 2015 Jun 5;97:871-910. doi: 10.1016/j.ejmech.2014.07.044. Epub 2014 Jul 24. Eur J Med Chem. 2015. PMID: 25073919 Review.
Cited by
-
Regioselective Synthesis of Cycloalkane-fused Pyrazolo[4,3-e]pyridines through Tandem Reaction of 5-aminopyrazoles, Cyclic Ketones and Electron-rich Olefins.Curr Org Synth. 2024;21(7):947-956. doi: 10.2174/0115701794269765231204064930. Curr Org Synth. 2024. PMID: 39044704
-
Synthesis of N-Alkyl-3-[2-oxoquinolin-1(2H)-yl]propanoic Acid Derivatives and Related Compounds: Cytotoxicity and EGFR Inhibition of Some Propanamide Derivatives.ACS Omega. 2024 Jul 17;9(30):32789-32798. doi: 10.1021/acsomega.4c03114. eCollection 2024 Jul 30. ACS Omega. 2024. PMID: 39100360 Free PMC article.
-
Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach.Pharmaceuticals (Basel). 2023 Jun 11;16(6):865. doi: 10.3390/ph16060865. Pharmaceuticals (Basel). 2023. PMID: 37375812 Free PMC article.
-
Copper(II) Complexes with 1-(Isoquinolin-3-yl)heteroalkyl-2-ones: Synthesis, Structure and Evaluation of Anticancer, Antimicrobial and Antioxidant Potential.Int J Mol Sci. 2023 Dec 19;25(1):8. doi: 10.3390/ijms25010008. Int J Mol Sci. 2023. PMID: 38203181 Free PMC article.
-
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery.Pharmaceuticals (Basel). 2022 Nov 8;15(11):1366. doi: 10.3390/ph15111366. Pharmaceuticals (Basel). 2022. PMID: 36355538 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources